ARCT
Arcturus Therapeutics Holdings Inc.Company with tickers: ARCT
CIK
1768224
CUSIP
03969T109
Shares Outstanding
28,423,069
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,061,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $30,992,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $21,527,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-28,931,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-26,964,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.95 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.95 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |